Literature DB >> 15857544

Physicians' ability to diagnose sepsis in newborns and critically ill children.

Joachim E Fischer1.   

Abstract

OBJECTIVE: To elucidate physicians' ability to correctly diagnose infection in critically ill children in three different situations: 1) post hoc adjudication (e.g., ward rounds, outcome determination in surveillance studies or controlled trials), 2) when decisions must be made (e.g., sepsis workup in suspected infection), c) and applying suggested adult consensus conference definitions in children.
METHOD: Appraisal of two previously published studies and a data simulation model.
SETTING: Data of the reviewed studies were obtained from a multidisciplinary neonatal and a pediatric intensive care unit in tertiary hospitals.
INTERVENTIONS: None. MAIN
RESULTS: In the first study reviewed, the post hoc adjudication of 167 consecutive cases of suspected infection was carried out by a fifth-year medical student and three senior consultants. The agreement of the three experts beyond chance in the 119 episodes not classifiable unanimously by a priori defined criteria into proven sepsis or no infection was poor. In the second study reviewed, the physicians provided daily predictions of the likelihood of infection (pretest probability) in premature infants and critically ill children (2567 hospitalization days). Estimated pretest probabilities provided at the time of sepsis workup showed a remarkable predictive accuracy (area under the receiver operating characteristic curve, 0.85). In the simulation model, in which catheter-related sepsis was assumed, correct classification of patients from a central and a peripheral culture decreased to 56% when a sensitivity of 70%-80% was assumed for blood cultures and amounted to 15% only when a sensitivity of 30%-50% was imputed.
CONCLUSION: Misclassification is a serious threat in post hoc adjudication of episodes or when consensus definitions rely on the application of criteria with imperfect sensitivity (e.g., the positivity of blood cultures in premature infants or children). This underscores the need to use probability-based categorizations such as probable and possible infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857544     DOI: 10.1097/01.PCC.0000161583.34305.A0

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  11 in total

Review 1.  Pediatric sepsis.

Authors:  Brittany Mathias; Juan C Mira; Shawn D Larson
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

2.  Clinical signs to identify late-onset sepsis in preterm infants.

Authors:  Jolita Bekhof; Johannes B Reitsma; Joke H Kok; Irma H L M Van Straaten
Journal:  Eur J Pediatr       Date:  2012-12-28       Impact factor: 3.183

3.  Optimizing the Use of Antibacterial Agents in the Neonatal Period.

Authors:  Joseph B Cantey
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

4.  Gram-Negative Bacilli in Infants Hospitalized in The Neonatal Intensive Care Unit.

Authors:  Sameer J Patel; Nicole Green; Sarah A Clock; David A Paul; Jeffrey M Perlman; Theoklis Zaoutis; Yu-Hui Ferng; Luis Alba; Haomiao Jia; Elaine L Larson; Lisa Saiman
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

5.  Bacterial sepsis in Brazilian children: a trend analysis from 1992 to 2006.

Authors:  Cristina Malzoni Ferreira Mangia; Niranjan Kissoon; Otavio Augusto Branchini; Maria Cristina Andrade; Benjamin Israel Kopelman; Joe Carcillo
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

6.  Biomarker Phenotype for Early Diagnosis and Triage of Sepsis to the Pediatric Intensive Care Unit.

Authors:  Beata Mickiewicz; Graham C Thompson; Jaime Blackwood; Craig N Jenne; Brent W Winston; Hans J Vogel; Ari R Joffe
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

7.  Prospective audit and feedback on antibiotic use in neonatal intensive care: a retrospective cohort study.

Authors:  Nisha Thampi; Prakesh S Shah; Sandra Nelson; Amisha Agarwal; Marilyn Steinberg; Yenge Diambomba; Andrew M Morris
Journal:  BMC Pediatr       Date:  2019-04-11       Impact factor: 2.125

8.  Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network.

Authors:  Grace Li; Julia Anna Bielicki; A S M Nawshad Uddin Ahmed; Mohammad Shahidul Islam; Eitan Naaman Berezin; Clery B Gallacci; Ruth Guinsburg; Carlos Eduardo da Silva Figueiredo; Rosilene Santarone Vieira; Andre Ricardo Silva; Cristiane Teixeira; Paul Turner; Ladin Nhan; Jaime Orrego; Paola Marsela Pérez; Lifeng Qi; Vassiliki Papaevangelou; Pinelope Triantafyllidou; Elias Iosifidis; Emmanuel Roilides; Kosmas Sarafidis; Dasaratha Ramaiah Jinka; Raghuprakash Reddy Nayakanti; Praveen Kumar; Vikas Gautam; Vinayagam Prakash; Arasar Seeralar; Srinivas Murki; Hemasree Kandraju; Sanjeev Singh; Anil Kumar; Leslie Lewis; Jayashree Pukayastha; Sushma Nangia; Yogesha K N; Suman Chaurasia; Harish Chellani; Stephen Obaro; Angela Dramowski; Adrie Bekker; Andrew Whitelaw; Reenu Thomas; Sithembiso Christopher Velaphi; Daynia Elizabeth Ballot; Trusha Nana; Gary Reubenson; Joy Fredericks; Suvaporn Anugulruengkitt; Anongnart Sirisub; Pimol Wong; Sorasak Lochindarat; Suppawat Boonkasidecha; Kanchana Preedisripipat; Tim R Cressey; Pongsatorn Paopongsawan; Pagakrong Lumbiganon; Dounghatai Pongpanut; Pra-Ornsuda Sukrakanchana; Philippa Musoke; Linus Olson; Mattias Larsson; Paul T Heath; Michael Sharland
Journal:  Arch Dis Child       Date:  2019-08-24       Impact factor: 3.791

9.  Microcirculatory changes in term newborns with suspected infection: an observational prospective study.

Authors:  Irene Alba-Alejandre; Stephan Hiedl; Orsolya Genzel-Boroviczény
Journal:  Int J Pediatr       Date:  2013-01-10

10.  Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis.

Authors:  Beata Mickiewicz; Graham C Thompson; Jaime Blackwood; Craig N Jenne; Brent W Winston; Hans J Vogel; Ari R Joffe
Journal:  Crit Care       Date:  2015-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.